全文获取类型
| 收费全文 | 3426328篇 |
| 免费 | 245224篇 |
| 国内免费 | 10832篇 |
专业分类
| 耳鼻咽喉 | 45653篇 |
| 儿科学 | 112587篇 |
| 妇产科学 | 94619篇 |
| 基础医学 | 485291篇 |
| 口腔科学 | 94585篇 |
| 临床医学 | 321164篇 |
| 内科学 | 667117篇 |
| 皮肤病学 | 78153篇 |
| 神经病学 | 283683篇 |
| 特种医学 | 129330篇 |
| 外国民族医学 | 1047篇 |
| 外科学 | 500658篇 |
| 综合类 | 72241篇 |
| 现状与发展 | 6篇 |
| 一般理论 | 1354篇 |
| 预防医学 | 273619篇 |
| 眼科学 | 76662篇 |
| 药学 | 250744篇 |
| 12篇 | |
| 中国医学 | 7486篇 |
| 肿瘤学 | 186373篇 |
出版年
| 2019年 | 27772篇 |
| 2018年 | 38989篇 |
| 2017年 | 29759篇 |
| 2016年 | 33981篇 |
| 2015年 | 38387篇 |
| 2014年 | 52956篇 |
| 2013年 | 80682篇 |
| 2012年 | 107866篇 |
| 2011年 | 114181篇 |
| 2010年 | 68459篇 |
| 2009年 | 64872篇 |
| 2008年 | 106123篇 |
| 2007年 | 112382篇 |
| 2006年 | 114024篇 |
| 2005年 | 109468篇 |
| 2004年 | 105004篇 |
| 2003年 | 101262篇 |
| 2002年 | 97894篇 |
| 2001年 | 159407篇 |
| 2000年 | 163648篇 |
| 1999年 | 138181篇 |
| 1998年 | 40389篇 |
| 1997年 | 35861篇 |
| 1996年 | 35856篇 |
| 1995年 | 34601篇 |
| 1994年 | 31943篇 |
| 1993年 | 30059篇 |
| 1992年 | 108509篇 |
| 1991年 | 104926篇 |
| 1990年 | 101725篇 |
| 1989年 | 97888篇 |
| 1988年 | 89920篇 |
| 1987年 | 88174篇 |
| 1986年 | 83191篇 |
| 1985年 | 79493篇 |
| 1984年 | 59460篇 |
| 1983年 | 50743篇 |
| 1982年 | 30270篇 |
| 1981年 | 27000篇 |
| 1979年 | 53066篇 |
| 1978年 | 37690篇 |
| 1977年 | 31628篇 |
| 1976年 | 29864篇 |
| 1975年 | 31462篇 |
| 1974年 | 37547篇 |
| 1973年 | 35953篇 |
| 1972年 | 33554篇 |
| 1971年 | 31222篇 |
| 1970年 | 28905篇 |
| 1969年 | 27360篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
21.
F. Murina R. Felice S. Di Francesco L. Nelvastellio I. Cetin 《Gynecological endocrinology》2020,36(5):431-435
AbstractThis study is a single-center, retrospective analysis of postmenopausal women presenting with dyspareunia and vulvar pain, aiming to evaluate relative effectiveness of vestibular CO2 laser therapy as a treatment. Three monthly sessions of laser were performed to each patient and thereafter a three-months follow-up was stablished. A total number of 72 patients undergoing vestibular laser treatment were recruited from patient files in the period between 2016 and 2018. Among these, 39 women also received a concomitant treatment with ospemifene (60?mg/day) during the study period. There was a statistically significant reduction of all the symptoms in both groups up to the three month follow-up. Regarding dryness and dyspareunia, the relief tent to be more prominent in the ospemifene?+?laser group at all follow-ups and remained statistically significant at three-month follow-up. Specifically, vestibular dryness was significantly lower in the ospemifene?+?laser group compared with the laser treatment group (?87% vs???34%, respectively), and the vestibular health score started declining faster in the ospemifene?+?laser group. Although, additional research is needed to understand the mechanism of action, our data shows that a combination regimen of laser and ospemifene may improve clinical effectiveness for long-term treatment of symptoms associated with the under-recognized genitourinary syndrome of menopause. 相似文献
22.
23.
24.
25.
26.
Daniel J. Snyder Thomas R. Kroshus Aakash Keswani Evan B. Garden Karl M. Koenig Kevin J. Bozic David S. Jevsevar Jashvant Poeran Calin S. Moucha 《The Journal of arthroplasty》2019,34(4):613-618
Background
Nursing Home Compare (NHC) ratings, created and maintained by Medicare, are used by both hospitals and consumers to aid in the skilled nursing facility (SNF) selection process. To date, no studies have linked NHC ratings to actual episode-based outcomes. The purpose of this study was to evaluate whether NHC ratings are valid predictors of 90-day complications, readmission, and bundle costs for patients discharged to an SNF after primary total joint arthroplasty (TJA).Methods
All SNF-discharged primary TJA cases in 2017 at a multihospital academic health system were queried. Demographic, psychosocial, and clinical variables were manually extracted from the health record. Medicare NHC ratings were then collected for each SNF. For patients in the Medicare bundle, postacute and total bundle cost was extracted from claims.Results
Four hundred eighty-eight patients were discharged to a total of 105 unique SNFs. In multivariate analysis, overall NHC rating was not predictive of 90-day readmission/major complications, >75th percentile postacute cost, or 90-day bundle cost exceeding the target price. SNF health inspection and quality measure ratings were also not predictive of 90-day readmission/major complications or bundle performance. A higher SNF staffing rating was independently associated with a decreased odds for >75th percentile 90-day postacute spend (odds ratio, 0.58; P = .01) and a 90-day bundle cost exceeding the target price (odds ratio = 0.69; P = .02) but was similarly not predictive of 90-day readmission/complications.Conclusion
Results of our study suggest that Medicare's NHC tool is not a useful predictor of 90-day costs, complications, or readmissions for SNFs within our health system. 相似文献27.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献28.
29.
30.
Xiaoxuan Liu Ameenat L. Solebo Livia Faes Sophie Beese Tasanee Braithwaite Matthew E. Round 《Ocular immunology and inflammation》2020,28(6):898-907
ABSTRACT